W.R. Berkley Corp’s ProKidney PROK Stock Holding History

W.R. Berkley Corp’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-48,399	Closed	-$482K	–	517
2022 Q2	$482K	Hold	48,399	–	–	0.02%	468
2022 Q1	$479K	Sell	48,399 -1,601	-3%	-$15.8K	0.02%	490
2021 Q4	$495K	Buy	+50,000	New	+$494K	0.03%	438

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

W.R. Berkley Corp's PROK Position: Q3 2022 in Review

W.R. Berkley Corp sold out of ProKidney (PROK) in Q3 2022, closing a stake of 48,399 shares — an estimated $482K sold.

W.R. Berkley Corp first reported a position in PROK in Q4 2021 and held it in 3 quarters. The position peaked at $495K in Q4 2021. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

W.R. Berkley Corp reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
W.R. Berkley Corp sold 48,399 ProKidney shares in Q3 2022, an estimated $482K.
W.R. Berkley Corp first reported a position in ProKidney in Q4 2021 and held it in 3 quarters.
W.R. Berkley Corp's ProKidney position peaked at $495K in Q4 2021.
18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on W.R. Berkley Corp's 13F filing for Q3 2022, filed 14 Nov 2022.